Search
for
Sort by
Research 931–960 of 1000+
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- 83. Use of Activated PRP on Alopecia: Systematic Review and Metaanalyses
- 294 Extensive alopecia areata is reversed by IL-12/23p40 cytokine antagonism
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study
- Patient preferences in the treatment of alopecia areata: A review of the literature
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Optimization and Transfollicular Delivery of Finasteride Loaded PLGA Nanoparticles Laden Carbopol Gel for Treatment of Hair Growth Stimulation
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- The Roles of Exosomes in Regulating Hair Follicle Growth
- Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- AAPS and PSRC 2016 Abstract Supplement
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Recovery of nail dystrophy potential new therapeutic indication of tofacitinib
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Dermatological Indications: Alopecia Areata
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Understanding autoimmunity of vitiligo and alopecia areata
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- Quality of Life and Mood Status Disturbances in Cohabitants of Patients with Alopecia Areata: A Cross-Sectional Study in a Spanish Population
- Causes and therapeutic limitations of clinical alopecia and the advent of human pluripotent stem cell follicular transplantation